🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ICYMI: Zipalertinib meets primary endpoint in the phase 2b REZILIENT 1 trial. 📰 Read the preliminary findings and more in ILCN: bit.ly/43Z91AT #LCSM

How does the microbiome influence lung cancer & immunotherapy? Stephen V Liu, MD talks with Drs. Arielle Elkrief & Bertrand Routy on a new episode of #LungCancerConsidered about the latest research, what we still don’t know, and more! 🎧 Listen now: bit.ly/MI-NSCLC

Catch part 2 of our webinar series "Smoking Cessation at Lung Examination." Leading experts explore best practices, challenges & research from the NCI #SCALECollaboration in the context of lung cancer screening. 🗓️ Don't miss this vital discussion! 🔗 bit.ly/SCLEPNCI

On the new #LungCancerConsidered in Italian, Alfredo Addeo MD moderates a conversation with Francesco & Cecilia Pompili MD PhD FACS. Tune in as they discuss managing resectable Stage III NSCLC & new treatment options. 🎧 Listen now: bit.ly/ItalianVTB

#ELCC25 Recap: Drs. Chih-Hsin Yang and Pérol break down the latest findings from the MARIPOSA trial. Learn more in ILCN: bit.ly/42tiNca

#ELCC25 Recap: World-renowned pathology expert, Dr. Keith Kerr, receives the 2025 Heine H. Hansen Award. 🏆 Read the highlights in ILCN: bit.ly/3EjmysI

On #LungCancerConsidered, Narjust Florez, MD, FASCO & Corey Langer break down key data from #ELCC25, including MARIPOSA, ORCHARD & SOHO-01 trials—plus insights on managing treatment toxicity in lung cancer. 🎧 Listen now: bit.ly/LCC25ELCC #ELCC25

The SCALE trials are on a mission to uncover key elements of successful smoking cessation programs. Find out more in ILCN: bit.ly/4j9lOpk

⭐ The IASLC STARS Program empowers patient advocates to drive lung cancer research. Learn about the program and how to get involved in ILCN: bit.ly/4lqB5Dx

ICYMI: Foritinib gains momentum in China for ALK-positive NSCLC. 📰 Read the latest developments in ILCN: bit.ly/3G1dF7R

This year, Narjust Florez, MD, FASCO recorded #LungCancerConsidered live from #TexasLung25 with Drs. Eric K. Singhi, MD & Misty Dawn Shields. They discuss effective patient communication in oncology, the top tips for first visits, education, and more! 🎧 Listen now: bit.ly/TL25LCC

Catch the #LungCancerConsidered episode in Turkish! 🇹🇷 Explore first-line therapies for EGFR-mutant NSCLC with Ece Cali Daylan, MD, PhD, Dr. Özden Altundağ & Dr. Saadettin Kiliçkap. 🎧 Listen now: bit.ly/LCCTurkishEGFR

This week's #LungCancerConsidered episode was recorded live from #TexasLung25! Narjust Florez, MD, FASCO & Mihaela Aldea break down RET-positive NSCLC—diagnostic challenges, treatment options & what clinicians need to know. 🎧 Listen now: bit.ly/TL25RET

Are you an early-career lung cancer researcher? Apply now for the Jen Brock Memorial Award and attend #WCLC25 with $7,500 in support for travel, registration & networking! 🗓️ Deadline: May 16, 2025 🔗 bit.ly/JBMAward

Thank you RadOncResearch for the reminder to make members' voices heard in the #IASLC Board of Directors election! 🗳️ Don't forget to check your inbox for your ballot from [email protected] — and vote by May 22, 2025! #IASLC2025 #LeadershipMatters #VoteNow

🗳 Have you voted yet? The #IASLC 2025 Board of Directors Election is your chance to shape the future of global lung cancer leadership. ✅ Vote by May 22, 2025 📩 Check your email for a ballot from: [email protected] 🔍 Missing your ballot? Contact: [email protected]

What were the biggest lung cancer takeaways from #AACR25? 🧬 In the latest #LungCancerConsidered, Stephen V Liu, MD & Christine Lovly, MD, PhD, FASCO break down results from the Beamion LUNG-1, AENEAS, and SignPost studies. 🎧 Listen now: bit.ly/AACR25Highligh…

Calling all healthcare professionals, leaders & those with lived experience in thoracic cancer care! We need your voice in the AIRSPACE study by #IASLC to improve global tobacco dependency services. ☑ Confidential 🗓️Open till May 23, 2025 👉Take the survey here:

What happens when a lung cancer awareness advocate becomes a patient? Stephen V Liu, MD speaks with Dr. Bryant Lin, who shares his diagnosis, EGFR mutation experience, and how it inspired a course on cancer care at Stanford on #LungCancerConsidered. 🎧 Listen: bit.ly/LinTMLC

🚨 Call for Workshop Proposals – #ACLC2025 🚨 The #IASLC Asia Conference on Lung Cancer is now accepting pre-conference workshop proposals! Open to IASLC members only. Proposals should be interactive, regional, and educational. 📅 Deadline: June 5, 2025 🔗